NCT01469130 2020-10-05A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid TumorsArray BioPharmaPhase 1 Completed21 enrolled
NCT01352273 2020-09-30MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E MutationsArray BioPharmaPhase 1 Completed69 enrolled
NCT01449058 2017-10-02A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid TumorsArray BioPharmaPhase 1 Completed139 enrolled